Dr. Sudhir Bhargav Vyakaranam, MD

Dr. Vyakaranam practices at Nephrology Physicians in Elkhart, Indiana.

Dr. Vyakaranam's NPI, 1407019037, was assigned on July 3, 2008. Dr. Vyakaranam holds Indiana license 01069102A.

Dr. Vyakaranam's primary practice is Nephrology Physicians, at 820 Waterbury Park Dr, Elkhart, IN 46517 in Elkhart County. The practice phone is (574) 273-6767.

Dr. Vyakaranam's primary practice is Nephrology Physicians in Elkhart, Indiana. Dr. Vyakaranam is also affiliated with Elkhart General Hospital. The medical group on file is Nephrology Physicians. Dmand AI also links Dr. Vyakaranam to 4 more hospitals and 5 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vyakaranam practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Vyakaranam's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Vyakaranam's licenses on file in 3 states: Indiana, Ohio and Pennsylvania.

CMS data shows 1,751 Medicare services from Dr. Vyakaranam across 13 procedure codes in 2024, for 559 Medicare patients. Medicare paid $179,086 for them.

CMS counts 559 Medicare patients who saw Dr. Vyakaranam in 2024. The largest group is 75 to 84, with 208 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 2.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vyakaranam's median patient age at 71, with 48% women.

In 2024, Dr. Vyakaranam wrote 5,126 Medicare Part D claims for 611 patients. 89% of them were for generic drugs. CMS names the drug for 4,888 of them, across 68 drugs with 11 or more claims each, at $560,940 in total drug cost. In 2023, CMS named 4,304 claims across 59 drugs.

Dr. Vyakaranam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vyakaranam as offering telehealth.

Dmand AI links 3 papers to Dr. Vyakaranam in 2020. 2020 was the busiest year, with 3. Dr. Vyakaranam has published most often in Semin Thromb Hemost. Dr. Vyakaranam's most frequent co-authors are Mathew Marsee, MD, Jason H. Hwang, DO and Sashi Kiran Inkollu, MBBS.

CMS Open Payments shows 181 general payments to Dr. Vyakaranam from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Mallinckrodt Enterprises LLC paid the most, $12,684.